Prevention of colonic aberrant crypt foci by dietary feeding of chalcone and 2-hydroxychalcone in male F344 rats

Journal of Toxicologic Pathology

Volumn 15, Issue 3, 2002, Pages 137-143

  Kohno, Hiroyuki ^a   Yamaguchi, Kazue ^a   Taima, Miki ^a   Tanaka, Takuji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aberrant crypt foci; Chalcones; Inhibition; OST; QR; Rat colon

Indexed keywords

EID: 33749048583     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.15.137     Document Type: Article

References (37)

1. Rogers AE, Zeisel SH, and Groopman J. Diet and carcinogenesis. Carcinogenesis 1993; 14: 2205-2217.
2. Ames BN and Gold LS. Environmental pollution, pesticides and the prevention of cancer: misconceptions. FASEB J 1997; 11: 1041-1052.
3. Wattenberg EW. Inhibition of carcinogenesis by nonnutrient constituents of the diet. In: Food and Cancer Prevention: Chemical and Biological Aspects, Waldron KW, Johnson IT, and Fenwick GR (eds), Cambridge, UK: The Royal Society of Chemistry, 12-23, 1993.
4. Tanaka T. Chemoprevention of colon carcinogenesis by non-nutritive compounds in foods. In: Carcinogenic and Anticarcinogenic Factors in Food, Eisenbrand G, Dayan AD, Elias PS, Grunow W, and Schlatter. 1 (eds), Weinheim: WIEEY-VCH Verlag, 365-391, 2000.
5. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55-71.
6. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, and Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 1992; 13: 1509-1512.
7. Stavric B. Role of chemopreventers in human diet. Clin Biochem 1994; 27: 319-332.
8. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, and Ogawa H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 1997; 18: 957-965.
9. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Satoh K, Hara A, and Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of β-carotene. Cancer Res 1994; 54: 4653-4659.
10. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Fukutani K, Tanaka T, and Ogawa H. Modulation of N-methyl-N-amylnitrosamineinduced rat oesophageal tumorigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997; 18: 761-769.
11. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A, Sumida T, Fukutani K, Tanaka T, and Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res 1997; 57: 246 - 252.
12. Anto RJ, Sukumaran K, Kuttan G, Rao MN, Subbaraju V, and Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett 1995; 97: 33-37.
13. Satomi Y. Inhibitory effects of 3′-methyl-3-hydroxychalcone on proliferation of human malignant tumor cells and on skin carcinogenesis. Int J Cancer 1993; 55: 506-514.
14. Ramanathan R, Das NP, and Tan CH. Inhibitory effects of 2hydroxy chalcone and other flavonoids on human cancer cell proliferation. Int J Oncol 1993; 3: 155-159.
15. Edenharden R, von Petersdorff I, and Rauscher R. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3methylimidazo[4,5-f|quinoline (IQ) and other heterocyclic amine mutagens from cooked food. Mutat Res 1993; 287: 261-274.
16. Yit CC and Das NP. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett 1994; 82: 65-72.
17. Yamamoto S, Aizu E, Jiang H, Nakadake T, Kiyoto I, Wang JC, and Kato R. The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis 1991; 12: 317-323.
18. Wattenberg LW, Coccia JB, and Galbraith AR. Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. Cancer Lett 1994; 83: 165-169.
19. Wattenberg L. Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J Cell Biochem 1995; 22(Suppl): 162-168.
20. Makita H, Tanaka T, Fujitsuka H, Tatematsu N, Satoh K, Hara A, and Mori H. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Res 1996; 56: 4904-909.
21. Tanaka T, Kawabata K, Kakumoto M, Makita H, Hara A, Mori H, Satoh K, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Koshimizu K, and Ohigashi H. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 1997; 18: 2155-2161.
22. Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K, and Ohigashi H. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 1998; 58: 2550-2556.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
24. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res 1992; 52: 2024s-2029s.
25. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, and Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
26. Srivastava S, Verma M, and Henson DE. Biomarkers for early detection of colon cancer. Clin Cancer Res 2001; 7: 1118-1126.
27. Stopera SA and Bird RP. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci. Cytobios 1993; 73: 73-88.
28. Tanakamaru Z, Mori I, Nishikawa A, Furukawa F, Takahashi M, and Mori H. Essential similarities between spontaneous and MeIQx-promoted aberrant crypt foci in the F344 rat colon. Cancer Lett 2001; 172: 143-149.
29. Stoll R, Renner C, Hansen S, Palme S, Klein C, Belling A, Zeslawski W, Kamionka M, Rehm T, Muhlhahn P, Schumacher R, Hesse F, Kaluza B, Voelter W, Engh RA, and Holak TA. Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry 2001; 40: 336-344.
30. Sohn OS, Fiala ES, Requeijo SP, Weisburger JH, and Gonzalez FJ. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res 2001; 61: 8435-8440.
31. Fiala ES, Bobotas G, Kulakis C, Wattenberg LW, and Weisburger JH. Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1,2dimethylhydrazine. Biochem Pharmacol 1977; 26: 1763- 1768.
32. Wattenberg LW, Lam LK, Fladmoe A, and Borchert P. Inhibitors of colon carcinogenesis. Cancer 1977; 40: 2432-2435.
33. Tanaka T and Mori H. Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J Toxicol Pathol 1996; 9: 139-149.
34. Fiala ES. Inhibition of carcinogen metabolism and action by disulfiram, pyrazole, and related compounds. In: Inhibition of Tumor Induction and Development, Zedeck MS, and Lipkin M (eds), New York: Plenum Publ, 23-69, 1981.
35. Sumiyoshi H and Wargovich MJ. Chemoprevention of 1,2dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 1990; 50: 5084-5087.
36. Henderson MC, Miranda CL, Stevens. IF, Deinzer ML, and Buhler DR. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 2000; 30: 235-251.
37. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985; 45: 1-8.